Inventor · disambiguated record
Nagasree Chakka
Also filed as: CHAKKA NAGASREE
30 granted patents·10 pending applications·366 citations·filing 2004–2021
97Inventor score
Files withXENON PHARMACEUTICALS INC19AMGEN INC6CHAFEEV MIKHAIL5TEIJIN PHARMA LTD3ZALICUS PHARMACEUTICALS LTD3
Top patents by PatentIndex Score
40 records- 0195US9663508B2Biaryl acyl-sulfonamide compounds as sodium channel inhibitorsAMGEN INC·Filed 2014·Granted May 30, 2017·29 cites·20 claims
- 0295US8466188B2Use of spiro-oxindole compounds as therapeutic agentsCHAFEEV MIKHAIL·Filed 2007·Granted Jun 18, 2013·63 cites·1 claims
- 0395US7700641B2Spiro-oxindole compounds and their uses as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2006·Granted Apr 20, 2010·39 cites·41 claims
- 0493US7767677B2Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitorsXENON PHARMACEUTICALS INC·Filed 2005·Granted Aug 3, 2010·34 cites·10 claims
- 0592US7592343B2Pyridazine-piperazine compounds and their use as stearoyl-CoA desaturase inhibitorsXENON PHARMACEUTICALS INC·Filed 2005·Granted Sep 22, 2009·22 cites·6 claims
- 0692US7335658B2Pyridazine derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2004·Granted Feb 26, 2008·59 cites·95 claims
- 0791US8263606B2Spiro-oxindole compounds and their use as therapeutic agentsCHAFEEV MIKHAIL·Filed 2009·Granted Sep 11, 2012·16 cites·25 claims
- 0891US8106087B2Spiro-oxindole compounds and their uses as therapeutic agentsCHAFEEV MIKHAIL·Filed 2009·Granted Jan 31, 2012·19 cites·6 claims
- 0991US7547698B2Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (SCD)XENON PHARMACEUTICALS INC·Filed 2005·Granted Jun 16, 2009·18 cites·9 claims
- 1089US8415370B2Spiro-oxindole compounds and their uses as therapeutic agentsCHAFEEV MIKHAIL·Filed 2012·Granted Apr 9, 2013·10 cites·13 claims
- 1185US7919484B2Combination therapyXENON PHARMACEUTICALS INC·Filed 2006·Granted Apr 5, 2011·10 cites·18 claims
- 1284US8377968B2N-piperidinyl acetamide derivatives as calcium channel blockersZALICUS PHARMACEUTICALS LTD·Filed 2009·Granted Feb 19, 2013·7 cites·2 claims
- 1382US8916580B2Spiro-oxindole compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2013·Granted Dec 23, 2014·4 cites·8 claims
- 1481US9096522B2N-piperidinyl acetamide derivatives as calcium channel blockersZALICUS PHARMACEUTICALS LTD·Filed 2013·Granted Aug 4, 2015·5 cites·11 claims
- 1581US8569344B2N-piperidinyl acetamide derivatives as calcium channel blockersPAJOUHESH HASSAN·Filed 2012·Granted Oct 29, 2013·5 cites·5 claims
- 1680US9505749B2Quinazolinone compounds and derivatives thereofAMGEN INC·Filed 2013·Granted Nov 29, 2016·3 cites·49 claims
- 1780US9012443B2Bicyclic aryl and heteroaryl sodium channel inhibitorsAMGEN INC·Filed 2012·Granted Apr 21, 2015·6 cites·32 claims
- 1879US11332459B2Benzimidazole derivatives and their usesTEIJIN PHARMA LTD·Filed 2018·Granted May 17, 2022·2 cites·16 claims
- 1978US8026360B2Substituted pyridazines as stearoyl-CoA desaturase inhibitorsXENON PHARMACEUTICALS INC·Filed 2009·Granted Sep 27, 2011·3 cites·5 claims
- 2075US7754711B2Pyridazine derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2005·Granted Jul 13, 2010·2 cites·6 claims
- 2173US9458178B2Spiro-oxindole compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2014·Granted Oct 4, 2016·1 cites·4 claims
- 2272US9365522B2Pyrazole amide derivativeAMGEN INC·Filed 2015·Granted Jun 14, 2016·2 cites·14 claims
- 2372US7919496B2Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymesXENON PHARMACEUTICALS INC·Filed 2005·Granted Apr 5, 2011·1 cites·10 claims
- 2470US9340549B2Oxazolidinone compounds and derivatives thereofAMGEN INC·Filed 2013·Granted May 17, 2016·1 cites·10 claims
- 2568US9334269B2Carboxamides as inhibitors of voltage-gated sodium channelsBREGMAN HOWARD·Filed 2011·Granted May 10, 2016·3 cites·6 claims
- 2667US7763618B2Pyridyl derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2004·Granted Jul 27, 2010·2 cites·43 claims
- 2760US2011009414A9Heterocyclic derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 2856US2017114075A1Spiro-oxindole compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2953US2012122909A9Spiro-oxindole compounds and their uses as therapeutic agentsCHAFEEV MIKHAIL·Filed 2011·Application pending·0 cites
- 3050US8383628B2Pyridyl derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2010·Granted Feb 26, 2013·0 cites·15 claims
- 3149US2016175315A1N-piperidinyl acetamide derivatives as calcium channel blockersZALICUS PHARMACEUTICALS LTD·Filed 2015·Application pending·0 cites
- 3249US2023167073A1Aryl or heteroaryl derivativeTEIJIN PHARMA LTD·Filed 2021·Application pending·0 cites
- 3349US2009069408A1Tricyclic compounds useful in treating iron disordersXENON PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 3448US2008227823A1Amide derivatives as calcium channel blockersPAJOUHESH HASSAN·Filed 2008·Application pending·0 cites
- 3547US2013079354A1Pyridyl derivatives and their use as therapeutic agentsABREO MELWYN·Filed 2012·Application pending·0 cites
- 3647US2008234384A1Biaryl and biheteroaryl compounds useful in treating iron disordersXENON PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 3745US12492185B2Benzimidazole derivatives and their usesTEIJIN PHARMA LTD·Filed 2020·Granted Dec 9, 2025·0 cites·5 claims
- 3843US7951805B2Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturaseXENON PHARMACEUTICALS INC·Filed 2005·Granted May 31, 2011·0 cites·16 claims
- 3943US2007105820A1Oxindole compounds and their uses as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 4042US9346798B2Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitorsAMGEN INC·Filed 2013·Granted May 24, 2016·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Nagasree Chakka files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →